| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 15,495,800 | 15,069,600 | 14,961,000 | 15,666,800 | | Cost of Revenue | 112,400 | (36,169,200) | 36,169,200 | (118,900) | | | Gross Profit | 15,383,400 | 51,238,800 | (21,208,200) | 15,785,700 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 13,953,300 | 50,544,000 | (22,089,300) | 14,411,600 | | Non Recurring |
-
|
-
| 141,400 |
-
| | Others | 67,900 | 71,100 | 71,900 | 71,600 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,362,200 | 623,700 | 667,800 | 1,302,500 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (352,500) |
-
|
-
|
-
| | Earnings Before Interest And Taxes | 1,009,700 | 623,700 | 667,800 | 1,302,500 | | Interest Expense | 116,100 | 115,900 | 118,400 | 116,500 | | Income Before Tax | 893,600 | 507,800 | 549,400 | 1,186,000 | | Income Tax Expense | 313,200 | 176,400 | (271,300) | 435,500 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 580,400 | 331,400 | 820,700 | 750,500 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 580,400 | 331,400 | 820,700 | 750,500 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $580,400 | $331,400 | $820,700 | $750,500 |
|
0.45% Nasdaq 
0.20%
Income Statement
